Tel:
Fax:
Email:
Creative Biolabs

Mouse Anti-Human FGF-basic Monoclonal Antibody (CBP3901)

[CAT#: NAB2012471LS]

Anti-FGF-basic Monoclonal Antibody [Biotin]

Host Species:
Mouse
Species Reactivity:
Human
Applications:
ELISA

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Immunogen

Recombinant human bFGF

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Isotype

IgG1

Clone Number

CBP3901

Applications

ELISA

Relevant Diseases

Brain Tumors; Alzheimer's Disease; Parkinson's Disease; Neurocutaneous Syndromes

Research Areas

Neuroinflammation; Neurodegeneration
Product Properties

Form

Liquid

Formulation

PBS, pH 7.2, containing 0.09% sodium azide.

Concentration

1.0 mg/mL

Purification

Affinity Chromatography

Purity

>95%, as determined by Coomassie stained SDS-PAGE.

Shipping

The product is shipped at 4°C. Upon receipt, store it immediately at the recommended temperature.

Storage

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Research Use Only

For research use only, not for diagnostic or therapeutic use.
Target

Target

FGF2

Official Name

FGF2

Full Name

basic fibroblast growth factor

Alternative Names

FGF2; BFGF; FGF-2; FGFB; HBGF-2; fibroblast growth factor 2

Gene ID

2247(Human); 14173(Mouse)

Uniprot ID

P09038(Human); P15655(Mouse)
Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
USA

Tel:

Fax:

Email:

UK

Tel:

Email:

Germany

Tel:

Email:

Inquiry Basket
compare

Send inquiry

WEBINAR
NEURAL CIRCUITS OF SURVIVAL: HOW THE BRAIN ORCHESTRATES DEFENSIVE BEHAVIOR
11 AM EDT, June 25, 2025